Macquarie Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.95M | Sell |
|
|||||
|
2025
Q1 | $8.09M | Buy |
|
|||||
|
2024
Q4 | $7.23M | Buy |
|
|||||
|
2024
Q3 | $8.85M | Sell |
|
|||||
|
2024
Q2 | $12.9M | Sell |
|
|||||
|
2024
Q1 | $26M | Sell |
|
|||||
|
2023
Q4 | $66M | Sell |
|
|||||
|
2023
Q3 | $70.2M | Buy |
|
|||||
|
2023
Q2 | $18.6M | Buy |
|
|||||
|
2023
Q1 | $16.5M | Buy |
|
|||||
|
2022
Q4 | $14.7M | Buy |
|
|||||
|
2022
Q3 | $13.9M | Buy |
|
|||||
|
2022
Q2 | $10.6M | Sell |
|
|||||
|
2022
Q1 | $11.6K | Sell |
|
|||||
|
2021
Q4 | $13.6M | Sell |
|
|||||
|
2021
Q3 | $20.5M | Buy |
|
|||||
|
2021
Q2 | $24.5M | Buy |
|
|||||
|
2021
Q1 | $19.5M | Buy |
|
|||||
|
2020
Q4 | $17.1M | Sell |
|
|||||
|
2020
Q3 | $20M | Buy |
|
|||||
|
2020
Q2 | $18.1M | Sell |
|
|||||
|
2020
Q1 | $42.5M | Buy |
|
|||||
|
2019
Q4 | $38.9M | Sell |
|
|||||
|
2019
Q3 | $92.4M | Sell |
|
|||||
|
2019
Q2 | $99.2M | Sell |
|
|||||
|
2019
Q1 | $116M | Sell |
|
|||||
|
2018
Q4 | $204M | Sell |
|
|||||
|
2018
Q3 | $284M | Buy |
|
|||||
|
2018
Q2 | $213M | Buy |
|
|||||
|
2018
Q1 | $191M | Sell |
|
|||||
|
2017
Q4 | $232M | Buy |
|
|||||
|
2017
Q3 | $219M | Buy |
|
|||||
|
2017
Q2 | $167M | Sell |
|
|||||
|
2017
Q1 | $180M | Sell |
|
|||||
|
2016
Q4 | $211M | Sell |
|
|||||
|
2016
Q3 | $248M | Sell |
|
|||||
|
2016
Q2 | $439M | Buy |
|
|||||
|
2016
Q1 | $260M | Buy |
|
|||||
|
2015
Q4 | $268M | Buy |
|
|||||
|
2015
Q3 | $224M | Buy |
|
|||||
|
2015
Q2 | $269M | Buy |
|
|||||
|
2015
Q1 | $179M | Buy |
|
|||||
|
2014
Q4 | $27.8M | Buy |
|
|||||
|
2014
Q3 | $26.1M | Sell |
|
|||||
|
2014
Q2 | $25M | Buy |
|
|||||
|
2014
Q1 | $23.9M | Buy |
|
|||||
|
2013
Q4 | $20.9M | Buy |
|
|||||
|
2013
Q3 | $15.2M | Buy |
|
|||||
|
2013
Q2 | $13.3M | Buy |
|